Skip to main content

Table 2 Relationship between hsa-miR-125a-5p expression and clinical pathological factors in lung cancinoma

From: Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

  

hsa-miR-125a-5p

Variable

Patients

Low expression(%)

High expression(%)

p value

Gender

    

Male

33

14 (42.4)

19 (57.6)

 

Female

19

6 (31.6)

13 (68.4)

0.439b

Age

    

≤ 60

28

11 (39.3)

17 (60.7)

 

> 60

24

9 (37.5)

15 (62.5)

1.000b

Histology type

    

Squamous cancer

22

9 (40.9)

13 (59.1)

 

Adenocarcinoma

30

11 (36.7)

19 (63.3)

0.780b

Pathological grade

    

I

8

4 (50.0)

4 (50.0)

 

II

28

11 (39.3)

17 (60.7)

 

III

16

5 (31.3)

11 (68.7)

0.380c

Pathological stage

    

I

18

12 (66.7)

6 (33.3)

 

II

15

5 (33.3)

10 (66.7)

 

III

19

3 (15.8)

16 (84.2)

0.002c

Lymph node status

    

No metastasis

32

16 (50.0)

16 (50.0)

 

Metastasis

20

4 (20.0)

16 (80.0)

0.042a

  1. a Two-sided Fisher's Exact Test.
  2. b Chi-square Test
  3. c Mann-whitney Test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us